Form 8-K - Current report:
SEC Accession No. 0001437749-25-017298
Filing Date
2025-05-16
Accepted
2025-05-16 08:18:18
Documents
16
Period of Report
2025-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250206_8k.htm   iXBRL 8-K 31916
2 EXHIBIT 99.1 ex_775746.htm EX-99.1 142018
7 logo.jpg GRAPHIC 7464
  Complete submission text file 0001437749-25-017298.txt   336815

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20250516.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250516_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250516_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250516_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20250206_8k_htm.xml XML 2843
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25957012
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)